This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Aktiengesellschaft. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Karoline Dorsch-Häsler: Innovator in Eukaryotic Expression Systems
Introduction
Karoline Dorsch-Häsler is a prominent inventor based in Zurich, Switzerland. She has made significant contributions to the field of biotechnology, particularly in the development of eukaryotic expression systems. Her innovative work has led to advancements that are crucial for various applications in genetic engineering and molecular biology.
Latest Patents
Karoline holds a patent for an "Enhancer for eukaryotic expression systems." This patent describes an enhancer located in the upstream region of the major immediate early gene of human cytomegalovirus. The enhancer has been isolated and is noted to be more active than that from SV40, with a wide host cell spectrum. This makes it suitable for eukaryotic expression systems, where it can be incorporated either upstream or downstream of the structural gene or the regulation region. She has 1 patent to her name.
Career Highlights
Karoline Dorsch-Häsler has been associated with Hoechst Aktiengesellschaft, a leading company in the pharmaceutical and biotechnology sectors. Her work at Hoechst has allowed her to focus on innovative solutions that enhance the efficiency of gene expression in various biological systems.
Collaborations
Throughout her career, Karoline has collaborated with notable scientists, including Bernhard W Fleckenstein and Frank Weber. These collaborations have contributed to her research and the successful development of her patented technologies.
Conclusion
Karoline Dorsch-Häsler is a trailblazer in the field of biotechnology, with her work on eukaryotic expression systems paving the way for future innovations. Her contributions continue to impact the scientific community and advance the understanding of genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
